Evidence map›Paper›PMID 37070548›Full record

ArticleThe EMBO journal2023

Dosage sensitivity to Pumilio1 variants in the mouse brain reflects distinct molecular mechanisms.

Salvatore Botta, Nicola de Prisco, Alexei Chemiakine, Vicky Brandt, Maximilian Cabaj, Purvi Patel, Ella Doron-Mandel, Colton J Treadway, Marko Jovanovic, Nicholas G Brown and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Salvatore BottaDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-6873-2107
Nicola de PriscoDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.
Alexei ChemiakineDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0001-8129-9830
Vicky BrandtDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.
Maximilian CabajDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.
Purvi PatelProteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0003-1914-3004
Ella Doron-MandelDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Colton J TreadwayDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.ORCID 0000-0002-4304-2556
Marko JovanovicDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Nicholas G BrownDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.ORCID 0000-0002-6141-0164
Rajesh K SoniProteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-4556-4358
Vincenzo A GennarinoDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-3312-6991
Columbia University Irving Medical Center · USColumbia University · USUniversity of North Carolina at Chapel Hill · USUniversity of Campania "Luigi Vanvitelli" · IT

Funding

Spindle Assembly Checkpoint SilencingR35GM128855 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Nicholas Gene Brown · 2018 to 2026
$4.1M
Deciphering the Role of the Pumilio1 in Two Distinct Neurological DiseasesR01NS109858 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Vincenzo Alessandro Gennarino · 2019 to 2026
$4.1M
Extensive multiplexing of protein nucleic-acid interactions to comprehensively study gene expression regulation from chromatin to mRNA degradationR01HG012216 · NHGRI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GUTTMAN, MITCHELL, JOVANOVIC, MARKO · 2022 to 2025
$3.1M
Defining the programmed proteome rejuvenation underlying gametogenesisR01AG071869 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRAR, GLORIA ANN, JOVANOVIC, MARKO · 2021 to 2025
$2.9M
Regulation of Protein Production Dynamics:RNA Binding Proteins and the Ribosome CodeR35GM128802 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI JOVANOVIC, MARKO · 2018 to 2022
$2.3M
NHGRI NIH HHS R01 HG012216NIA NIH HHS R01 AG071869NIGMS NIH HHS R35 GM128802NIGMS NIH HHS R35 GM128855NINDS NIH HHS R01 NS109858
6 · The paper itself

Abstract

Different mutations in the RNA-binding protein Pumilio1 (PUM1) cause divergent phenotypes whose severity tracks with dosage: a mutation that reduces PUM1 levels by 25% causes late-onset ataxia, whereas haploinsufficiency causes developmental delay and seizures. Yet PUM1 targets are derepressed to equal degrees in both cases, and the more severe mutation does not hinder PUM1's RNA-binding ability. We therefore considered the possibility that the severe mutation might disrupt PUM1 interactions, and identified PUM1 interactors in the murine brain. We find that mild PUM1 loss derepresses PUM1-specific targets, but the severe mutation disrupts interactions with several RNA-binding proteins and the regulation of their targets. In patient-derived cell lines, restoring PUM1 levels restores these interactors and their targets to normal levels. Our results demonstrate that dosage sensitivity does not always signify a linear relationship with protein abundance but can involve distinct mechanisms. We propose that to understand the functions of RNA-binding proteins in a physiological context will require studying their interactions as well as their targets.

Indexed as

BrainRNA-Binding ProteinsAnimalsMiceMutationSeizuresRNA-Binding ProteinsAGO2brain interactomeFMRPRBP interactomeRNA-binding protein interactome

Identifiers

PMID37070548
PMCPMC10233381
OpenAlexW4366239106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.